NikhilPalekarMD
Psychiatry • Stony Brook, NYGeriatric Psychiatry, Neuropsychiatry, Psychopharmacology, Integrative Psychiatry
Vice-Chair for Ambulatory Clinical Affairs; Director- Stony Brook Center of Excellence for Alzheimer's Disease; Director- Alzheimer’s Disease Clinical Trials Program; Director- Division of Geriatric Psychiatry; Director- Geriatric Psychiatry Fellowship Program; Medical Director-ACO/CIN Depression Program. Associate Professor of Psychiatry, Neurology and Medicine at Stony Brook University Hospital.
Dr. Palekar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 Nicolls Rd
T 10-20
Stony Brook, NY 11794Phone+1 631-954-2323
Summary
- Dr. Nikhil Palekar is a geriatric psychiatrist in Stony Brook, NY and is affiliated with multiple hospitals in the area, including NewYork-Presbyterian/Weill Cornell and Stony Brook University Hospital. He specializes in memory disorders, geriatric psychiatry, neuropsychiatry, and psychopharmacology and is experienced in Alzheimer’s disease, neuroimaging and clinical trials.
Education & Training
SUNY Downstate Health Sciences UniversityFellowship, Geriatric Psychiatry, 2008 - 2009- SUNY Downstate Health Sciences UniversityResidency, Psychiatry, 2004 - 2008
B.J. Medical College - University of PuneClass of 2003
Certifications & Licensure
NY State Medical License 2010 - 2026- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Geriatric Psychiatry
Awards, Honors, & Recognition
- 2016 Planetree Physician of the Year 2016
Clinical Trials
- PREvent First Episode Relapse (PREFER) Start of enrollment: 2004 Nov 01
- Study of the Efficacy and Safety of Various Anti-inflammatory Agents in Participants With Mild Cognitive Impairment or Mild Alzheimer's Disease Start of enrollment: 2021 Oct 28
- A Study of Seltorexant in Participants With Probable Alzheimer's Disease Start of enrollment: 2022 May 19
- Join now to see all
Publications & Presentations
PubMed
- Connected through movement: a feasibility study of online mindfulness-based dance/movement therapy for older adults with age-related cognitive decline during COVID-19.Minjung Shim, Melissa Kavanaugh, Clarissa Lacson, Natasha Goldstein-Levitas, Hansoo Chang
Aging & Mental Health. 2024-12-01 - Loss of cholinergic input to the entorhinal cortex is an early indicator of cognitive impairment in natural aging of humans and mice.Mala R Ananth, John D Gardus, Chuan Huang, Nikhil Palekar, Mark Slifstein
Research Square. 2024-02-29 - 6 citationsPotential of Transcranial Direct Current Stimulation in Alzheimer's Disease: Optimizing Trials Toward Clinical Use.Giuseppina Pilloni, Leigh E Charvet, Marom Bikson, Nikhil Palekar, Min-Jeong Kim
Journal of Clinical Neurology. 2022-07-01
Press Mentions
A Study of 12,000 People Found That Taking This One Supplement May Lower Your Dementia Risk by 40%March 16th, 2023
Alzheimer's: Drugs Targeting Dementia-Causing Particles Could Be Trialed in Two YearsSeptember 24th, 2018
Alzheimer’s Foundation of America Grant to Stony Brook Medicine to Investigate Development of More Targeted TreatmentJune 6th, 2018- Join now to see all
Professional Memberships
- Member
- American Association for Geriatric PsychiatryMember
- Alzheimer’s Association International Society to Advance Research and TreatmentMember
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
